Cell surface receptors are all 'talk' in T cell stimulationJune 13, 2008Understanding the mechanisms that drive healthy immune responses is important when it comes to combating autoimmune diseases, which occur when cells that should attack invading organisms turn on the body instead. In a study published in the June 13, 2008, issue of Immunity, Tufts researcher Stephen Bunnell, PhD, describes how cell surface receptors cooperate to generate immune responses in a process referred to as costimulation. To reveal how these receptors communicate, Bunnell, assistant professor of pathology at Tufts University School of Medicine and a member of the immunology program faculty at the Sackler School of Graduate Biomedical Sciences, formulated a fluorescent imaging technique that reveals the dynamic movements of proteins within living T cells. T cells play an essential role defending the body against viruses and bacteria. To mount these defenses, T cells must sense these pathogens via cell surface receptors known as antigen receptors. T cells are much more likely to 'see' the invading organisms when a second group of proteins, known as integrins, becomes involved. Integrins are also cell surface receptors, and act as adhesive hooks that allow the T cell to latch onto its environment. "What we are providing here is insight into how these receptors collaborate, or 'talk' to one another," says Bunnell. First author Ken Nguyen, a graduate student in immunology in Bunnell's laboratory, found that a particular integrin, VLA-4, influences how cellular structures known as SLP-76 microclusters move within the responding T cell. These structures, which were first discovered by Bunnell, are assembled by the antigen receptor and relay information that is essential for T cell activation. "SLP-76 is a molecular building block that is employed by both antigen receptors and integrins. When VLA-4 is not involved, SLP-76 microclusters move away from the antigen receptor, which causes them to fall apart. We discovered that VLA-4 prevents the separation of SLP-76 microclusters from the antigen receptor. This keeps each SLP-76 microcluster intact for a longer time, and favors the transmission of stimulatory signals," says Bunnell.
Actin filaments are a major component of the 'skeleton' that enables cells to move. In activated T cells, many actin filaments grow at one end and fall apart at the other. These actin filaments 'flow' away from the growing end, much like a treadmill. Nguyen and colleagues showed that these flows drive SLP 76 from the antigen receptor, but are slowed when VLA-4 is engaged. "By altering the movement of actin within the cell, the integrin is collaborating with the antigen receptor to immobilize these complexes and make them survive over time," says Bunnell. "We have known for some time that integrin signaling and T cell costimulation contribute to autoimmunity. Bunnell's images allow us to see that these can be related phenomena: integrins sensitize the immune system to antigens," says Naomi Rosenberg, PhD, dean of the Sackler School of Graduate Biomedical Sciences and vice dean for research at Tufts University School of Medicine. In previous research, integrins and antigen receptors were thought of as working individually, in terms of geography and mechanism. Earlier studies by Bunnell, and recent studies by other investigators, have led researchers to believe that antigen receptors are most effective when located near integrins. Importantly, this study indicates that integrins influence the transmission of signals through the same complexes used by the T cell antigen receptor. "You need to understand the communication between the receptors in order to intelligently intervene and enhance the response to a virus or bacteria, or inhibit a destructive response," says Bunnell. Bunnell's future research will examine how integrins alter the mechanical properties of activated T cells. By studying how integrins influence the SLP-76 complex, Bunnell will gain insights into the costimulatory processes that enable normal immune responses, and go awry in autoimmune diseases. Tufts University, Health Sciences | |||||||||||||||||||||
|
Related Cell Surface Current Events and Cell Surface News Articles MIT paves way to 'artificial nose' MIT biological engineers have found a way to mass-produce smell receptors in the laboratory, an advance that paves the way for "artificial noses" to be created and used in a variety of settings. New results help predict treatment response in colorectal cancer Genetic testing can identify a group of patients with advanced colorectal cancer who are likely to survive on average twice as long if treated with the drug cetuximab, late breaking results show. Vaccine against HER2-positive breast cancer offers complete protection in lab Researchers at Wayne State University have tested a breast cancer vaccine they say completely eliminated HER2-positive tumors in mice - even cancers resistant to current anti-HER2 therapy - without any toxicity. Monitoring immune responses in disease A recent study published in Clinical Immunology, the official journal of the Clinical Immunology Society (CIS), describes a new method enabling the detection of multiple parameters of single human cells. New method to overcome multiple drug resistant diseases developed by Stanford researchers Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them. First step towards switching off breast cancer and leukaemia Australian scientists have identified a way to 'switch off' a molecule, a key player in the molecular processes that trigger breast cancer and certain forms of leukaemia. USC researchers identify alternate pathway that leads to palate development Researchers at the University Of Southern California School Of Dentistry have uncovered another clue behind the causes of cleft palate and the process that leads to palate formation. Research exposes new target for malaria drugs The malaria parasite has waged a successful guerrilla war against the human immune system for eons, but a study in this week's Journal of Biological Chemistry has exposed one of the tricks malaria uses to hide from the immune proteins, which may aid in future drug development. A viral cloaking device Viruses achieve their definition of success when they can thrive without killing their host. Now, biologists Pamela Bjorkman and Zhiru Yang of the California Institute of Technology have uncovered how one such virus, prevalent in humans, evolved over time to hide from the immune system. Discovery of a mechanism that regulates cell movement A study performed by researchers at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with researchers at the Instituto de Biología Molecular of the CSIC, reveal a mechanism that controls the movement of cells in a tissue by regulating cell adhesion. More Cell Surface Current Events and Cell Surface News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||